ダウンロード数: 217
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| 11_1316.pdf | 386.32 kB | Adobe PDF | 見る/開く |
| タイトル: | 尿路性器悪性腫瘍治療時の血液変化に対するCepharanthinの使用経験 |
| その他のタイトル: | USE OF "CEPHARANTHIN" FOR THE HEMATOLOGICAL CHANGES DURING TREATMENTS IN MALIGNANT NEOPLASM OF THE UROGENITAL SYSTEM. |
| 著者: | 谷村, 実一  定延, 和夫 佐藤, 公彦 三国, 友吉 |
| 著者名の別形: | TANIMURA, Jitsukazu SADANOBU, Kazuo SATO, Kimihiko MIKUNI, Tomoyoshi |
| 発行日: | Dec-1965 |
| 出版者: | 京都大学医学部泌尿器科学教室 |
| 誌名: | 泌尿器科紀要 |
| 巻: | 11 |
| 号: | 12 |
| 開始ページ: | 1316 |
| 終了ページ: | 1323 |
| 抄録: | "Cepharanthin" was administered at the d o sages of 3.0 grams or 6.0 grams daily to 17 patients, a total of 19 cases, with malignant neoplasm of the urogenital system to prevent hematological side effects of therapeutic means for the malignancies. The results were satisfactory as follows. "Cepharanthin" administration during anti-tumor treatments, either with radiation or chemotherapeutic agents, could prevent leukopenia as well as decreases of red cell count and hemoglobin content. Slight nausea and anorexia were observed in 2 patients as possible side effects which disappeared after cessation of administion. There was no significant difference on the effects between the groups given Cepharnthin 3 grams and 6 grams daily. |
| URI: | http://hdl.handle.net/2433/112866 |
| 出現コレクション: | Vol.11 No.12 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。